Cited by 200CRISPR and Genetic EngineeringAnimal Genetics and ReproductionRegulation of Appetite and Obesity

Metabolic Pitfalls of CNS Cre-Based Technology

Open access
Harno, Erika, Cottrell, Elizabeth C., White, Anne·2013·Cell Metabolism

Abstract

Nestin-Cre mice have a significant metabolic phenotype that is hard to discern from current literature. Indeed, the Cre-lox system has numerous problems that can affect physiological parameters, and these are missed when the correct control strains are not used. Despite the increasing use of the Cre-lox system, these issues were not visible to the scientific community previously and may have affected published work. This makes it important to highlight the issues and raise awareness of the pitfalls of the Cre-lox system. Therefore, this perspective will discuss the impact of CNS and peripheral "off-target" Cre recombination on metabolic systems and describe the development of new approaches to obviate the difficulties.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2013.05.019

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ap2-Cre transgenic mice also express Cre recombinase in nonadipose tissues, including in the CNS.

    “However, these studies were confounded by the fact that ap2-Cre transgenic mice also express Cre recombinase in nonadipose tissues, including in the CNS (47).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Harno, E., Cottrell, E. C., & White, A.
Affiliations
University of Manchester (GB)
Corresponding author
White, Anne
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2013-07
Volume
18
Issue
1
Pages
21-28
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2093032500
Cited by
200
References
64
Citations by year
2026: 7 · 2025: 9 · 2024: 5 · 2023: 14 · 2022: 17 · 2021: 13 · 2020: 21 · 2019: 25 · 2018: 18 · 2017: 20 · 2016: 16 · 2015: 18 · 2014: 12 · 2013: 5
FWCI
7.61
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
Funders
  • AstraZeneca
  • National Institute for Health and Care Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
Cre-loxP system, central nervous system, metabolic phenotypes, control strains, conditional gene targeting
MeSH terms
Animals, Central Nervous System, DNA Nucleotidyltransferases, Protein-Lysine 6-Oxidase, Mice, Transgenic, Recombination, Genetic, Extracellular Matrix Proteins, Mice, Knockout, Gene Targeting, Integrases, Models, Animal, Mice, Nestin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review